Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 587 results for "sun pharmaceutical industries"

Sun to merge Ranbaxy, to keep brands alive
Deccan Chronicle

Sun to merge Ranbaxy, to keep brands alive

New Delhi: Ranbaxy Laboratories will cease to exist as a company after completion of the $4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets. The Ranbaxy entity will be merged into Sun Pharma and ... Deccan Chronicle, 2 hours ago

108 images for sun pharmaceutical industries

Business Today India, 1 week ago
The Hindu, 1 week ago
The Hindu, 1 week ago
South Florida Sun-Sentinel, 1 week ago
KFGO News, 1 week ago
Irish Times, 1 week ago, 1 week ago, 1 week ago, 1 week ago, 1 week ago

Sun Pharma continues to outglow its peers

Related to : Sun Pharmaceuticals Industries Ltd Sun Pharmaceuticals Industries Ltd BSE 17 Apr 14 | 12:00 AM 624.30 9.7 (1.58%) NSE 17 Apr 14 | 12:00 AM 625.05 11.2 (1.82%) Performance is built into the DNA of Sun Pharma. The ...
 Smart Investor1 day ago
Financial Express

Sun Pharma Acquires Ranbaxy Laboratories

Sun Pharmaceutical Industries Ltd plans to acquire Ranbaxy Laboratories Ltd for US$ 4 billion. The combination of Sun Pharma and Ranbaxy creates the fifth-largest specialty generics company in the world and the largest pharmaceutical company in ...
 Process Worldwide3 days ago Sun Pharmaceutical Industries Ltd to acquire Ranbaxy Laboratories Ltd  International Law Office5 days ago AFP - India-Japan-pharmaceutical-merger-Daiichi-Ranbaxy-Sun  Namibia Press Agency1 week ago Merger and Acquisition Round Up April 07 to 11, 2014  India Infoline1 week ago

Zenotech Laboratories: Updates on open offer

Sun Pharmaceutical Industries makes an open offer to acquire up to 9,693,332 fully paid up equity shares of face value of Rs 10 each from the shareholders of Zenotech Laboratories.
 Money Control5 days ago Sun Pharmaceutical Industries Ltd announces opern offer to the shareholders of Zenotech Laboratories  Reuters UK1 week ago Sun to make Rs 18cr open offer to Zenotech shareholders  Moneycontrol.com1 week ago Zenotech Laboratorie - Open Offer  Religare Securities1 week ago
Reuters India

Ranbaxy Drugs to be Rebranded as Sun Pharma to Help U.S. Reputation

According to Reuter's sources, Sun Pharmaceutical Industries will begin phasing out sales of generic drugs branded as Ranbaxy Laboratories in the United States, following Sun's $3.2 billion aquisition of Ranbaxy in early April. The rebranding of ...
 Pharmaceutical Manufacturing Magazine2 days ago Sun plans gradual phase-out of ranbaxy-branded drugs in us  4 Traders6 days ago Sun To Phase Out Ranbaxy Drugs In US  Businessworld India1 week ago Sun plans phasing out of Ranbaxy-brand drugs in US  Reuters India1 week ago
Finance 24

Investors back Sun Pharma's Ranbaxy move (AFP)

On the surface, Sun Pharma's $US3.2 billion ($A3.42 billion) purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may not look like a great deal. But Sun Pharmaceutical Industries' shares ...
 West Australian5 days ago Sun Pharma is able to revive Ranbaxy: investors  China Post6 days ago 'Sun Pharma can nurse Ranbaxy to health'  Finance 241 week ago Investors back Sun's Ranbaxy deal as well-calculated risky acquisition  Oman Tribune6 days ago
Reuters India

India's Glenmark pulls 2,900 bottles of ulcer drug in U.S.

MUMBAI, April 18 (Reuters) - India's Glenmark Pharmaceuticals Ltd is recalling some 2,900 bottles of its stomach ulcer drug ranitidine in the United States after a foreign tablet was found in one of the bottles. Medicines produced in India, which ...
 CNBC2 days ago India's Glenmark Recalls Nearly 3,000 Bottles Of Its Generic Ulcer Drug In US  International Business Times2 days ago Glenmark pulls 2,900 bottles of ulcer drug in US  Times of India2 days ago Glenmark recalls 2,900 bottles of ulcer drug in US  Deccan Chronicle2 days ago
Financial Express

Glenmark Pharma recalls stomach ulcer drug ranitidine in US

Medicines produced in India, which supplies about 40% of generic and over-the-counter drugs sold in the US, have come under increased scrutiny by the FDA. Summary In last 6 months alone, products made by some of India's largest drugmakers have ...
 Financial Express2 days ago Glenmark Pharmaceuticals recalls stomach ulcer drug ranitidine in US  Financial Express2 days ago
India Today

Sun rises on Ranbaxy

M.G. Arun New Delhi,April 18, 2014| UPDATED15:41 IST Dilip Shanghvi, CEO, Sun Pharmaceutical Industries Ltd. It isn't easy to cast Dilip Shanghvi, 58, Chief Executive Officer of Sun Pharmaceutical Industries Ltd into a classic CEO mould. He ...
 India Today2 days ago
Business Standard

US FDA penal actions hit pharma exports growth, may not exceed 5%

HYDERABAD: The sharply higher number of import alerts by the US drug regulator against medicines produced by several large Indian pharmaceutical companies will pull down pharmaceutical exports, industry officials have said. India, which exported ...
 Economic Times3 days ago FDA import alert on Sun's Gujarat plant, shares dip 6%  Business Standard1 month ago USFDA import alert on Sun's Gujarat plant  Sify1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharmaceutical industries
Get updated on latest news & your favorite topics right in your inbox!
More     Less